1 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|
2 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|
3 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
4 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
5 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
6 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
7 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
8 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
9 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
10 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
11 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
12 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
13 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
14 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
15 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
16 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
17 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
18 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
19 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
20 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
21 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
22 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
23 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
24 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
25 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
26 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
27 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
28 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
29 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
30 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
31 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
32 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
33 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
34 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
35 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
36 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
37 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
38 |
WARNER CHILCOTT COMPANY, LLC v. MYLAN, INC. et al |
3:11-cv-03262 |
D.N.J. |
|
|
|
|
39 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
40 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
41 |
OREXO AB v. MYLAN PHARMACEUTICALS INC. et al |
3:11-cv-03788 |
D.N.J. |
|
|
|
|
42 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
43 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
44 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
45 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
46 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
47 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
48 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
49 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
50 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|